Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Sato

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2014
Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseasesTetsuhiro Kanazawa, Yutaka Hiramatsu, Seiko Iwata, et al.
The Journal of Biological Chemistry|June 4, 2009
Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early proteinSanae Nakayama, Takayuki Murata, Kazutaka Murayama, et al.
Plos Pathogens|August 4, 2009
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complexYoshitaka Sato, Takumi Kamura, Noriko Shirata, et al.
Cancers|February 4, 2021
Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell LymphomaSeiyo Mabuchi, Fumiya Hijioka, Takahiro Watanabe, et al.
Pest Management Science|August 9, 2023
Suspension Concentrate crop protection formulation design and performance for low spray volume and UAS spray applicationMalcolm A Faers, Yoshitaka Sato, Emilia Hilz, et al.
Virology|February 27, 2021
RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cellsYusuke Yanagi, Yusuke Okuno, Yohei Narita, et al.
Frontiers in Microbiology|December 8, 2017
Characterization of a Suppressive <i>Cis</i>-acting Element in the Epstein-Barr Virus LMP1 PromoterMasahiro Yoshida, Takayuki Murata, Keiji Ashio, et al.
Cell Cycle (Georgetown, Tex.)|February 9, 2010
Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replicationYoshitaka Sato, Noriko Shirata, Takayuki Murata, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massilienseKeisuke Oka, Hiroshi Morioka, Motoki Eguchi, et al.
Nagoya Journal of Medical Science|November 2, 2020
Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 daysYoshitaka Sato, Mitsutaka Iguchi, Yoshiaki Kato, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2014
Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseasesTetsuhiro Kanazawa, Yutaka Hiramatsu, Seiko Iwata, et al.
The Journal of Biological Chemistry|June 4, 2009
Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early proteinSanae Nakayama, Takayuki Murata, Kazutaka Murayama, et al.
Plos Pathogens|August 4, 2009
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complexYoshitaka Sato, Takumi Kamura, Noriko Shirata, et al.
Cancers|February 4, 2021
Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell LymphomaSeiyo Mabuchi, Fumiya Hijioka, Takahiro Watanabe, et al.
Pest Management Science|August 9, 2023
Suspension Concentrate crop protection formulation design and performance for low spray volume and UAS spray applicationMalcolm A Faers, Yoshitaka Sato, Emilia Hilz, et al.
Virology|February 27, 2021
RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cellsYusuke Yanagi, Yusuke Okuno, Yohei Narita, et al.
Frontiers in Microbiology|December 8, 2017
Characterization of a Suppressive <i>Cis</i>-acting Element in the Epstein-Barr Virus LMP1 PromoterMasahiro Yoshida, Takayuki Murata, Keiji Ashio, et al.
Cell Cycle (Georgetown, Tex.)|February 9, 2010
Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replicationYoshitaka Sato, Noriko Shirata, Takayuki Murata, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massilienseKeisuke Oka, Hiroshi Morioka, Motoki Eguchi, et al.
Nagoya Journal of Medical Science|November 2, 2020
Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 daysYoshitaka Sato, Mitsutaka Iguchi, Yoshiaki Kato, et al.
Pageof 14